Prevention and control of cystic echinococcosis.

By P. Craig, D. McManus, M. Lightowlers, J. Chabalgoity, H. García, C. Gavidia, R. Gilman, Armando E. Gonzalez, M. Lorca, C. Náquira and 2 more. Lancet. Infectious Diseases (Print), 2007

665 citations recorded by the source corpus.

Human cystic echinococcosis (hydatid disease) continues to be a substantial cause of morbidity and mortality in many parts of the world. Elimination is difficult to obtain and it is estimated that, using current control options, achieving such a goal will take around 20 years of sustained efforts. Since the introduction of current (and past) hydatid control campaigns, there have been clear technological improvements made in the diagnosis and treatment of human and animal cystic echinococcosis, the diagnosis of canine echinococcosis, and the genetic characterisation of strains and vaccination against Echinococcus granulosus in animals. Incorporation of these new measures could increase the efficiency of hydatid control programmes, potentially reducing the time required to achieve effective prevention of disease transmission to as little as 5-10 years.

Subfields: Parasitology, Pathology and Forensic Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/c60c7f4890c357e8989a63a40fc9c9b9ec753c29

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. H. Wen
2. L. Vuitton
3. T. Tuxun
4. Jun Li
5. Wenbao Zhang
6. D. McManus
7. D. Vuitton

Citations in the corpus

• Echinococcosis: Advances in the 21st Century (2019, background): “Five thousand new CE cases are still diagnosed annually in Argentina, Brazil, Chile, Peru, and Uruguay (14, 15).”